ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7 Zacks Investment Research Other
Verrica to receive $10M payment as Ycanth gains approval in Japan The Business Journals Other
Celltrion’s Autoimmune Disease Treatment Aptozma Receives Product Approval in Japan Businesskorea Other
Esperion stock rises after Japan approves cholesterol drug NEXLETOL Investing.com Other
Esperion’s cholesterol drug NEXLETOL receives approval in Japan Investing.com Other
Alvotech Receives Marketing Approval In Japan For Three New Biosimilars Nasdaq Other
Esperion and Otsuka Receive Approval for NEXLETOL® in Japan for Hypercholesterolemia Treatment Quiver Quantitative Other
$10M Milestone Achievement: Verrica's Molluscum Drug YCANTH Receives Landmark Japan Approval via Torii Stock Titan Other
Major Win: Esperion's Cholesterol Drug NEXLETOL Gets Green Light in World's 3rd Largest CV Market Stock Titan Other
Alvotech and Fuji Pharma Receive Approval for Three New Biosimilars in Japan Quiver Quantitative Other
Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer Yahoo Finance Other
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC) Business Wire Other